Clinical Trial Detail

NCT ID NCT01985256
Title Study of a Retroviral Replicating Vector Given Intravenously to Patients Undergoing Surgery for Recurrent Brain Tumor
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Tocagen Inc.
Indications

malignant glioma

Therapies

Toca 511

Age Groups: adult

No variant requirements are available.